Viewing Study NCT02776033


Ignite Creation Date: 2025-12-25 @ 2:48 AM
Ignite Modification Date: 2026-02-28 @ 5:33 AM
Study NCT ID: NCT02776033
Status: COMPLETED
Last Update Posted: 2020-07-08
First Post: 2016-05-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Repeat Doses of GSK2982772 in Subjects With Psoriasis
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Psoriasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None tolerability View
None safety View
None GSK2982772 View
None RIP1 kinase inhibitor View
None psoriasis View